Clinical factors associated with discontinuation of ts/ bDMARDs in rheumatic patients from the BIOBADASER III registry
Abstract
Keywords
Rheumatoid arthritis; Spondyloarthritis; Ankylosing spondylitis; Psoriatic arthritis
Bibliographic citation
Prior-Español A, Sánchez-Piedra C, Campos J, Manero FJ, Pérez-García C, Bohórquez C, et al. Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry. Sci Rep. 2021 May 27;11(1):11091.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/6456This item appears in following collections
The following license files are associated with this item: